Cel-Sci
CVM
#9847
Rank
A$65.5 M
Marketcap
A$7.79
Share price
1.94%
Change (1 day)
-58.18%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of September 2025 : A$16.25 Million

According to Cel-Sci 's latest financial reports the company has A$16.25 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30A$16.56 M141.84%
2024-09-30A$6.85 M6.23%
2023-09-30A$6.44 M-81.7%
2022-09-30A$35.24 M-39.62%
2021-09-30A$58.37 M169.74%
2020-09-30A$21.64 M73.06%
2019-09-30A$12.5 M-12.38%
2018-09-30A$14.27 M372.57%
2017-09-30A$3.02 M-20.95%
2016-09-30A$3.82 M-53.23%
2015-09-30A$8.16 M-16.16%
2014-09-30A$9.74 M21724.9%
2013-09-30A$0.04 M-98.83%
2012-09-30A$3.8 M-12.98%
2011-09-30A$4.37 M-84.12%
2010-09-30A$27.54 M-28.73%
2009-09-30A$38.65 M3260.31%
2008-09-30A$1.15 M-90.64%
2007-09-30A$12.29 M13.48%
2006-09-30A$10.83 M320.21%
2005-09-30A$2.57 M-56.66%
2004-09-30A$5.94 M130.2%
2003-09-30A$2.58 M-32.45%
2002-09-30A$3.82 M-20.87%
2001-09-30A$4.83 M-75.34%
2000-09-30A$19.6 M117%
1999-09-30A$9.03 M-57.15%
1998-09-30A$21.07 M336.64%
1997-09-30A$4.82 M9.13%
1996-09-30A$4.42 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
A$13.42 M-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.31 B 1,843.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.01 B 86,128.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.69 B 4,200.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.26 B 20,012.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
A$27.54 B 169,361.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.36 B 2,141.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$4.52 M-72.18%๐Ÿ‡บ๐Ÿ‡ธ USA